.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Predict branded drug patent expiration
  • Identify first generic entrants

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Harvard Business School
Chinese Patent Office
Express Scripts
Fish and Richardson
Fuji
Federal Trade Commission
McKinsey
Colorcon
Daiichi Sankyo

Generated: June 26, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: perindopril erbumine

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Lupin Ltd
PERINDOPRIL ERBUMINE
perindopril erbumine
TABLET;ORAL078263ANDALupin Pharmaceuticals, Inc68180-235-01100 TABLET in 1 BOTTLE (68180-235-01)
Lupin Ltd
PERINDOPRIL ERBUMINE
perindopril erbumine
TABLET;ORAL078263ANDALupin Pharmaceuticals, Inc68180-236-01100 TABLET in 1 BOTTLE (68180-236-01)
Lupin Ltd
PERINDOPRIL ERBUMINE
perindopril erbumine
TABLET;ORAL078263ANDALupin Pharmaceuticals, Inc68180-237-01100 TABLET in 1 BOTTLE (68180-237-01)
Aurobindo Pharma
PERINDOPRIL ERBUMINE
perindopril erbumine
TABLET;ORAL079070ANDAAurobindo Pharma Limited65862-286-01100 TABLET in 1 BOTTLE (65862-286-01)
Aurobindo Pharma
PERINDOPRIL ERBUMINE
perindopril erbumine
TABLET;ORAL079070ANDAAurobindo Pharma Limited65862-286-5312000 TABLET in 1 BAG (65862-286-53)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Novartis
Moodys
McKinsey
Deloitte
Julphar
US Army
Daiichi Sankyo
Cipla
Mallinckrodt

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot